SCHEDULE Filed 2025-02-14 Event 2024-12-31 SEC 0000950170-25-021237 →

PERCEPTIVE ADVISORS LLC → TRINITY BIOTECH PLC TRIB

Stake: 20.90% Shares: 85,800,000 CUSIP: 896438504 Class: Class A Ordinary Shares, $0.0109 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Filer track record (6 filings): 0% 90d win rate, +0.0% 90d edge
High conviction ownership stake (20.9%)
Short interest building (+75.5% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

36 filings by this filer

35 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.66

31,360 shares short · +75.5% vs prior

Post-Filing Returns · since 2024-12-31 on TRIB

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 0.40 on closest trading day on/after 2024-12-31. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on TRINITY BIOTECH PLC

Filed	Form	Filer	Stake	Shares
2026-01-26	SCHEDULE	PERCEPTIVE ADVISORS LLC	9.90%	1,463,058,248	view →
2024-01-02	SC	MiCo IVD Holdings, LLC	—	—	view →
2024-01-02	SC	MiCo Co., Ltd.	—	—	view →

Other Filings by PERCEPTIVE ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-10-26	SCHEDULE 13D/A	LeonaBio, Inc.	—	1,889,403	view →
2026-10-14	SCHEDULE 13G	IRulya Therapeutics Inc.	—	—	view →
2026-10-01	SCHEDULE 13D/A	Kardigan, Inc.	—	8,254,144	view →
2026-09-23	SCHEDULE 13G	Nurix Therapeutics, Inc.	—	—	view →
2026-08-27	SCHEDULE 13D/A	Immatics N.V.	—	11,418,016	view →
2026-08-25	SCHEDULE 13D/A	LeonaBio, Inc.	19.99%	1,889,403	view →
2026-08-14	SCHEDULE 13D/A	Solid Biosciences Inc.	11.20%	12,046,579	view →
2026-08-14	SCHEDULE 13D/A	Nautilus Biotechnology, Inc.	9.10%	11,634,211	view →
2026-07-23	SCHEDULE 13G	Freenome, Inc.	—	—	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corporation IV	—	—	view →
2026-06-25	SCHEDULE 13D	Kardigan, Inc. KARD	8.90%	8,254,144	view →
2026-01-26	SCHEDULE	TRINITY BIOTECH PLC TRIB	9.90%	1,463,058,248	view →
2026-01-02	SCHEDULE	MeiraGTx Holdings plc MGTX	12.90%	10,441,562	view →
2025-02-21	SCHEDULE	Solid Biosciences Inc. SLDB	15.60%	11,934,679	view →
2025-01-31	SCHEDULE	Nautilus Biotechnology, Inc. NAUT	10.00%	12,594,211	view →
2023-10-17	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →
2023-06-06	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-30	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-05-25	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →
2023-04-25	SC	Cerevel Therapeutics Holdings, Inc.	—	—	view →

Showing 20 of 35

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →